Experts Highlight Key Topics to Watch at the 22nd International Myeloma Society Annual Meeting

The 22nd International Myeloma Society (IMS) Annual Meeting, taking place September 17–20, 2025, in Toronto, Canada, will highlight key advances across multiple myeloma research, including progress in precursor disease profiling and management, risk-adapted management strategies, immunotherapy optimization, and strategies for patients experiencing early relapse.¹ Additional sessions will spotlight late-breaking data on the predictive role of minimal residual disease (MRD), the efficacy of novel bispecific antibody combinations, and approaches for high-risk disease.